TrialIntegrative cancer therapies

A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients.

Qing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.